Во второй половине XX века произошла существенная эволюция знаний о гипертрофической кардиомиопатии. Об этом можно судить и по изменению терминологии, используемой для обозначения этого заболевания,-от функционального аортального стеноза к идиопатическому ги-пертрофическому аортальному стенозу, гипертрофической обструктивной кардиомиопатии и, наконец, гипертрофической кардиомиопатии (ГКМП). Последний термин является наиболее объективным, указывая на то, что обструкция выходного тракта левого желудочка (ВТЛЖ) не явля
<p><strong>Aim:</strong> The study was designed to evaluate the outcomes of aortic valve reimplantation (David procedure), as well as various techniques of aortic root reconstruction.<br /><strong>Methods:</strong> The results of 84 valve-sparing operations for thoracic aortic aneurysms and dissections were analyzed at B. Petrovsky Russian Research Center of Surgery over a period from 2007 to 2016. The first group (n = 42) consisted of patients after David procedure, the second group (n = 38) included patients after different methods of aortic root repair (fixation of commissures, leaflets plication, sinotubular ridge repair). 5-year results of surgical treatment were assessed.<br /><strong>Results:</strong> David procedure is characterized by good long-term results. There was no in-hospital and 5-year mortality in the first group, while 2 (5.3%) patients in the second group died in the early postoperative period. In both groups the reoperation rate was 2.4% and 8.3% respectively.<br /><strong>Conclusion:</strong> Valve-sparing aortic root repair is characterized by good survival rate, high freedom from reoperation and low incidence of complications.</p>
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.